Dr. Samuel Ani, MD

NPI: 1417199605
Total Payments
$2,235
2024 Payments
$985.05
Companies
17
Transactions
76
Medicare Patients
2,636
Medicare Billing
$372,590

Payment Breakdown by Category

Food & Beverage$2,235 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,235 76 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $622.49 22 $0 (2024)
Shionogi Inc $257.84 5 $0 (2024)
Melinta Therapeutics, LLC $249.98 9 $0 (2024)
Merck Sharp & Dohme LLC $217.76 12 $0 (2024)
Abbott Laboratories $140.76 1 $0 (2024)
PFIZER INC. $130.88 5 $0 (2024)
Gilead Sciences, Inc. $124.88 5 $0 (2024)
Boston Scientific Corporation $123.51 1 $0 (2018)
Novartis Pharmaceuticals Corporation $113.39 5 $0 (2018)
Astellas Pharma US Inc $54.18 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $985.05 29 Janssen Pharmaceuticals, Inc ($246.28)
2023 $770.24 31 Janssen Pharmaceuticals, Inc ($277.15)
2022 $243.30 10 Janssen Pharmaceuticals, Inc ($99.06)
2018 $236.90 6 Boston Scientific Corporation ($123.51)

All Payment Transactions

76 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/11/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $21.58 General
Category: VACCINE
11/24/2024 Melinta Therapeutics, LLC Rezzayo (Drug), Kimyrsa, Orbactiv Food and Beverage In-kind items and services $23.81 General
Category: ANTIFUNGALS
10/02/2024 Abbott Laboratories OPTIS (Device) Food and Beverage In-kind items and services $140.76 General
Category: Vascular
09/25/2024 Fisher Scientific Company L.L.C. Procalcitonin (Device) Food and Beverage In-kind items and services $21.29 General
Category: Infectious Disease
09/23/2024 Melinta Therapeutics, LLC Rezzayo (Drug), Kimyrsa, Orbactiv Food and Beverage In-kind items and services $23.53 General
Category: ANTIFUNGALS
09/19/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular & Metabolism
09/12/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.87 General
Category: Cardiovascular & Metabolism
09/09/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $25.68 General
Category: VACCINE
08/08/2024 Melinta Therapeutics, LLC Rezzayo (Drug), Kimyrsa, Orbactiv Food and Beverage In-kind items and services $26.47 General
Category: ANTIFUNGALS
08/07/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.54 General
Category: Cardiovascular & Metabolism
07/24/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $22.59 General
07/18/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Infections and Infectious Diseases
06/28/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.42 General
Category: Cardiovascular & Metabolism
06/26/2024 Melinta Therapeutics, LLC Rezzayo (Drug), Kimyrsa, Orbactiv Food and Beverage In-kind items and services $31.31 General
Category: ANTIFUNGALS
06/26/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $29.16 General
Category: Infections and Infectious Diseases
06/13/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $23.40 General
Category: Cardiovascular & Metabolism
06/12/2024 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $20.18 General
Category: INFECTIOUS DISEASE
06/06/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $26.63 General
Category: GASTROENTEROLOGY
06/05/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $20.18 General
Category: Cardiology
05/29/2024 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $18.58 General
Category: INFECTIOUS DISEASE
05/01/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.74 General
04/17/2024 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $18.16 General
Category: INFECTIOUS DISEASE
04/11/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $27.08 General
Category: Biological
04/05/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $23.49 General
Category: Cardiovascular & Metabolism
04/04/2024 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $19.12 General
Category: INFECTIOUS DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 1,073 1,830 $539,101 $143,721
2022 12 858 1,441 $398,505 $106,413
2021 8 312 507 $150,409 $45,084
2020 4 393 777 $370,997 $77,372
Total Patients
2,636
Total Services
4,555
Medicare Billing
$372,590
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 492 1,167 $318,385 $83,330 26.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 236 245 $96,471 $25,628 26.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 80 80 $36,234 $9,040 24.9%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 91 92 $27,189 $7,175 26.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 69 $15,260 $7,109 46.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 30 30 $21,474 $4,786 22.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 41 41 $11,723 $2,791 23.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 21 39 $7,800 $2,476 31.7%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 15 15 $2,595 $697.20 26.9%
92552 Test for hearing various pitches using earphone Office 2023 14 14 $1,400 $377.96 27.0%
36415 Insertion of needle into vein for collection of blood sample Office 2023 27 38 $570.00 $311.04 54.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 361 819 $218,211 $54,395 24.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 124 124 $65,092 $15,790 24.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 45 129 $19,860 $9,279 46.7%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 120 121 $32,708 $8,130 24.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 35 52 $8,290 $4,374 52.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 23 23 $19,425 $4,108 21.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 21 21 $5,250 $3,253 62.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 26 30 $13,691 $2,862 20.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 24 24 $8,870 $2,352 26.5%
99217 Hospital observation care on day of discharge Facility 2022 12 13 $3,198 $871.13 27.2%
92552 Test for hearing various pitches using earphone Office 2022 31 31 $3,100 $840.62 27.1%
36415 Insertion of needle into vein for collection of blood sample Office 2022 36 54 $810.00 $159.34 19.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 130 213 $97,980 $20,682 21.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 46 133 $20,550 $14,006 68.2%

About Dr. Samuel Ani, MD

Dr. Samuel Ani, MD is a Family Medicine healthcare provider based in Bay Shore, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2009. The National Provider Identifier (NPI) number assigned to this provider is 1417199605.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Ani, MD has received a total of $2,235 in payments from pharmaceutical and medical device companies, with $985.05 received in 2024. These payments were reported across 76 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,235).

As a Medicare-enrolled provider, Ani has provided services to 2,636 Medicare beneficiaries, totaling 4,555 services with total Medicare billing of $372,590. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine, Family Medicine
  • Location Bay Shore, NY
  • Active Since 04/02/2009
  • Last Updated 07/21/2022
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1417199605

Products in Payments

  • XARELTO (Drug) $622.49
  • Fetroja (Drug) $257.84
  • DIFICID (Drug) $170.50
  • Rezzayo (Drug) $158.58
  • OPTIS (Device) $140.76
  • WATCHMAN (Device) $123.51
  • ENTRESTO (Drug) $113.39
  • Kimyrsa (Drug) $91.40
  • ELIQUIS (Drug) $72.35
  • Veozah (Drug) $54.18
  • IGALMI (Drug) $52.46
  • GARDASIL (Biological) $47.26
  • XERAVA (Drug) $41.83
  • PAXLOVID (Drug) $31.10
  • PREVNAR 20 (Biological) $27.43
  • VOQUEZNA (Drug) $26.63
  • Miro3D (Device) $23.46
  • Procalcitonin (Device) $21.29
  • Repatha (Biological) $20.18
  • CALDOLOR (Drug) $13.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Bay Shore